Israel to Scrap COVID Passport, US, Portugal, California, CDC, Moderna, Pfizer, and Lilly<\/p>\n
Israel is planning to scrap its vaccine passport. US researchers estimate 73% of the US population now immune to Omicron, and more updates.<\/p>\n
If you like this content and want more, I am doing a special lifetime membership offer. Click here:<\/p>\n
Want to support this work?:
\nBuy me a coffee \ud83d\ude42
\nBecome my patron:
\nPayPal: <\/p>\n
#drbeen #koolbeens #COVID<\/p>\n
Disclaimer:
\nThis video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
\nPlease consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.<\/p>\n
URL list from Thursday, Feb. 17 2022<\/p>\n
DrBeen: Continuing Medical Education Online | USMLE Prep | CME and CE marketplace | Nurse Practitioner and Physician Assistant Training Programs | Medical Student Training<\/p>\n
Israel to scrap COVID passport system as omicron wanes<\/p>\n
Estimated 73% of US now immune to omicron: Is that enough?<\/p>\n
Home – COVID 19 scenario model hub<\/p>\n
Portugal drops most COVID-19 rules as Omicron ebbs<\/p>\n
California Introduces Post-Pandemic \u201cS.M.A.R.T.E.R.\u201d Plan For Next Phase Of Covid<\/p>\n
CDC to issue new mask guidance as COVID cases drop<\/p>\n
Moderna Says COVID-19 Booster To Be Ready By August, But Dicey If Omicron-Specific Needed: Reuters<\/p>\n
Pfizer and BioNTech Omicron-targeted vaccine delayed – BioNTech CEO<\/p>\n
Lilly’s bebtelovimab receives Emergency Use Authorization for the treatment of mild-to-moderate COVID-19 | Eli Lilly and Company<\/p>\n